LAUREN JONGSMA: Open Payments
NPI 1508428897 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 43 payments from 21 companies in 2025. Trend: 2023 $514 · 2024 $629 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $104 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Agios Pharmaceuticals, Inc. | 3 | $85 |
| ABBVIE INC. | 4 | $76 |
| BeOne Medicines USA, Inc. | 3 | $75 |
| Syndax Pharmaceuticals, Inc. | 4 | $71 |
| Incyte Corporation | 3 | $64 |
| Eisai Inc. | 2 | $59 |
| GlaxoSmithKline, LLC. | 2 | $45 |
Products named: TECVAYLI, KEYTRUDA, KISQALI, PYRUKYND, Lenvima, VENCLEXTA, MONJUVI, TEVIMBRA.
Industry payments across MI — which companies pay providers there.
